IL1B and hyperinsulinemic hypoglycemia, familial, 4: Early evidence into the efficacy of the therapeutic targeting IL-1β showed promise with reduced lesion development with an IL-1β deficiency, reduced intimal thickening with reduced IL-1 receptor expression, and reduced fatty lesion formation and MI in mice with over-expressed IL-1RA (Ridker, 2019).